CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...

Now, a new CRISPR-based test has been developed to diagnose PJP more ... transplant recipients, people with HIV/AIDS and patients on immune-suppressing drugs. Traditional diagnostic methods for PJP ...

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii ... transplant recipients, people with HIV/AIDS and patients on immune-suppressing drugs.

There are an estimated 300 CRISPR therapies in the development pipeline to treat diseases such as diabetes, HIV/AIDS and cancer. Most of these treatments are in the earliest stages of development.

Researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) — a life-threatening ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

Tulane University researchers have developed a CRISPR-based test that diagnoses ... transplant recipients, people with HIV/AIDS and patients on immune-suppressing drugs. Traditional diagnostic ...

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

Scientists are reporting the first use of the gene-editing tool CRISPR to try to cure a patient’s HIV infection by providing blood cells that were altered to resist the AIDS virus. The gene ...